Literature DB >> 8599519

Serum sensitivity of field isolates and laboratory strains of Brucella abortus.

F C Eisenschenk1, J J Houle, E M Hoffmann.   

Abstract

OBJECTIVE: To evaluate the ability of bovine complement to kill a variety of field isolates and laboratory strains of Brucella abortus.
DESIGN: The experimental approach was to determine the sensitivity of B abortus isolates to killing by bovine serum, and to document the role of complement in brucellacidal activity. SAMPLE POPULATION: Six laboratory isolates and 12 field isolates of B abortus were tested. PROCEDURE: The ability of B abortus to survive exposure to undiluted bovine serum for 2 hours at 37 C was assessed. The role of complement in killing was determined by examining the ability of heat (56 C for 60 minutes) and cobra venom factor to obliterate the activity in serum, and by detecting binding of the ninth component of bovine complement to serum-sensitive target cells.
RESULTS: Isolates of B abortus that were resistant to the bactericidal activity of normal bovine serum were revealed. These included field isolates and laboratory strains. Furthermore, the study confirmed earlier reports that bovine serum-mediated killing of B abortus is caused by the complement cascade.
CONCLUSIONS: Some isolates of B abortus, like other gram-negative bacteria, were resistant to complement-mediating killing. Resistance was associated with smooth colony morphology. Isolates lacking detectable O antigen were serum sensitive.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8599519

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Identification of genes required for chronic persistence of Brucella abortus in mice.

Authors:  P C Hong; R M Tsolis; T A Ficht
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.

Authors:  R Vemulapalli; Y He; L S Buccolo; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Depletion of Complement Enhances the Clearance of Brucella abortus in Mice.

Authors:  Gabriela González-Espinoza; Elías Barquero-Calvo; Esteban Lizano-González; Alejandro Alfaro-Alarcón; Berny Arias-Gómez; Esteban Chaves-Olarte; Bruno Lomonte; Edgardo Moreno; Carlos Chacón-Díaz
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

5.  Genomic Insertion of a Heterologous Acetyltransferase Generates a New Lipopolysaccharide Antigenic Structure in Brucella abortus and Brucella melitensis.

Authors:  Estrella Martínez-Gómez; Jonas Ståhle; Yolanda Gil-Ramírez; Amaia Zúñiga-Ripa; Mona Zaccheus; Ignacio Moriyón; Maite Iriarte; Göran Widmalm; Raquel Conde-Álvarez
Journal:  Front Microbiol       Date:  2018-05-25       Impact factor: 5.640

6.  Immunization with Brucella abortus S19Δper Conferred Protection in Water Buffaloes against Virulent Challenge with B. abortus Strain S544.

Authors:  Pallab Chaudhuri; Mani Saminathan; Syed Atif Ali; Gurpreet Kaur; Shiv Varan Singh; Jonathan Lalsiamthara; Tapas K Goswami; Ashwini K Singh; Sandeep K Singh; Praveen Malik; Raj K Singh
Journal:  Vaccines (Basel)       Date:  2021-12-02

7.  Pyruvate kinase is necessary for Brucella abortus full virulence in BALB/c mouse.

Authors:  Jianpeng Gao; Mingxing Tian; Yanqing Bao; Peng Li; Jiameng Liu; Chan Ding; Shaohui Wang; Tao Li; Shengqing Yu
Journal:  Vet Res       Date:  2016-08-25       Impact factor: 3.683

8.  Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.

Authors:  Neha Dabral; Grant N Burcham; Neeta Jain-Gupta; Nammalwar Sriranganathan; Ramesh Vemulapalli
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.